Similar articles

• Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas.

  Di Stefano G, Busi C, Derenzini M, Trerè D, Fiume L. Di Stefano G, et al. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):173-7. Ital J Gastroenterol Hepatol. 1998. PMID: 9675653
• A role for hepatic-directed chemotherapy in colorectal liver metastases.

  Ensminger WD. Ensminger WD. J Clin Oncol. 2005 Aug 1;23(22):4815-7. doi: 10.1200/JCO.2005.03.902. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009957 No abstract available.
• Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.

  Keegan-Rogers V, Wu CH, Wu GY. Keegan-Rogers V, et al. Targeted Diagn Ther. 1991;4:105-25. Targeted Diagn Ther. 1991. PMID: 1665717 Review. No abstract available.
• Bioluminescent imaging of hepatocellular carcinoma in live mice.

  Wang Y, Sun Z, Peng J, Zhan L. Wang Y, et al. Biotechnol Lett. 2007 Nov;29(11):1665-70. doi: 10.1007/s10529-007-9452-0. Epub 2007 Jul 4. Biotechnol Lett. 2007. PMID: 17609854
• [Chemotherapy for hepatocellular carcinoma].

  Okusaka T, Ueno H, Ikeda M. Okusaka T, et al. Gan To Kagaku Ryoho. 2004 Dec;31(13):2122-8. Gan To Kagaku Ryoho. 2004. PMID: 15628756 Review. Japanese.